Why Ocugen, Sorrento Therapeutics, and VBI Vaccines Are on the Move Today
The back half of 2022 is already shaping up to be a stock picker's market. Today's mixed trading session in the volatile healthcare sector is a case in point. For example, shares of the clinical-stage biotech Ocugen (NASDAQ: OCGN) were down by a hefty 9.5% and Sorrento Therapeutics' (NASDAQ: SRNE) equity was in the red by 5.62% at 11:02 a.m. ET Thursday.